A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression.

Goldsmith, D R, Rapaport, M H, Miller, B J·2016·Molecular Psychiatry

DOI 10.1038/mp.2016.3

Cited by (1,002)

Items 901–1,000 of 1,002

Elevated Serum Purine Levels in Schizophrenia: A Reverse Translational Study to Identify Novel Inflammatory Biomarkers
Zsüliet Kristóf, Mária Baranyi, Pál Tod, Paula Mut-Arbona, Kornél Demeter, István Bitter, Beáta Sperlágh · 2022 · The International Journal of Neuropsychopharmacology
Herpes simplex virus 1 infection on grey matter and general intelligence in severe mental illness
Dimitrios Andreou, Kjetil Nordbø Jørgensen, Stener Nerland, Torill Ueland, Anja Vaskinn, Unn Kristin Haukvik, Robert H. Yolken, Ole A. Andreassen, Ingrid Agartz · 2022 · Translational Psychiatry
Grey matter volume and its association with cognitive impairment and peripheral cytokines in excited individuals with schizophrenia
Yajuan Fan, Yuan Gao, Qingyan Ma, Binbin Zhao, Xiaoyan He, Feng Zhu, Wei Wang, Xiancang Ma, Yening Li · 2022 · Brain Imaging and Behavior
Depression trajectories and cytokines in schizophrenia spectrum disorders - A longitudinal observational study
Gunnhild E. Hoprekstad, Eirik Kjelby, Rolf Gjestad, Farivar Fathian, Tor Ketil Larsen, Solveig Klæbo Reitan, Maria A. Rettenbacher, Anja Torsvik, Silje Skrede, Erik Johnsen et al. · 2023 · Schizophrenia Research
Altered neutrophil-to-lymphocyte ratio in patients with non-affective first episode psychosis and its relationship with symptom severity and cognitive impairment
Kwan Keung Leung, Yip Chau Wong, Ka Sin Caroline Shea, Sheung Chun Chan, Wing Chung Chang, Yi Man Flora Mo, Sandra Sau Man Chan · 2023 · Scientific Reports
Depressed, stressed, and inflamed: C‐reactive protein linked with depression symptoms in midlife women with both childhood and current life stress
Christina A. Metcalf, Rachel L. Johnson, Korrina A. Duffy, Ellen W. Freeman, Mary Dupuis Sammel, Cynthia Neill Epperson · 2023 · Stress and Health
Influence of fluvoxamine on plasma interleukin-6 or clinical improvement in patients with major depressive disorder
Reiji Yoshimura, Asuka Katsuki, Kiyokazu Atake, Hikaru Hori, Ryohei Igata, Yuki Konishi · 2017 · Neuropsychiatric Disease and Treatment
An association between YKL ‐40 and type 2 diabetes in psychotic disorders
Ingrid Dieset, Ragni Helene Mørch, Sigrun Hope, Eva Zsuzsanna Hoseth, Elina Johanna Reponen, Jon Michael Gran, Monica Aas, Annika Elisabet Michelsen, Ted Reichborn‐Kjennerud, Ragnar Nesvåg et al. · 2018 · Acta Psychiatrica Scandinavica
Do Immune Dysregulations and Oxidative Damage Drive Mood and Psychotic Disorders?
Manuel Morrens, Violette Coppens, Sebastian Walther · 2019 · Neuropsychobiology
Tracking a dysregulated gut-brain axis with biomarkers of the microbiome
Emily G. Severance, Robert H. Yolken · 2019 · Biomarkers in Neuropsychiatry
New Insights Regarding Diagnosis and Medication for Schizophrenia Based on Neuronal Synapse–Microglia Interaction
Naotaka Izuo, Atsumi Nitta · 2021 · Journal of Personalized Medicine
Inflammatory monocyte gene signature predicts beneficial within group effect of simvastatin in patients with schizophrenia spectrum disorders in a secondary analysis of a randomized controlled trial
Mareike Aichholzer, Shiral S. Gangadin, Iris E. Sommer, Annemarie J. M. Wijkhuijs, Lot D. de Witte, René S. Kahn, Sabine Bahn, Hemmo A. Drexhage, Carmen Schiweck · 2022 · Brain Behavior & Immunity - Health
Transcranial sonography in psychiatry as a potential tool in diagnosis and research
Carsten Drepper, Julia M. Geissler, Giuseppe Mario Carmine Pastura, Rezzak Yılmaz, Daniela Berg, Marcel Romanos, Manfred Gerlach · 2017 · The World Journal of Biological Psychiatry
Integrative Analysis of DiseaseLand Omics Database for Disease Signatures and Treatments: A Bipolar Case Study
Chun Jing Wu, Bevan Emma Huang, Guang Chen, Timothy W. Lovenberg, David J. Pocalyko, Xiang Yao · 2019 · Frontiers in Genetics
Supervised pathway analysis of blood gene expression profiles in Alzheimer's disease
Elaheh Moradi, Mikael Marttinen, Tomi Häkkinen, Mikko O. Hiltunen, Matti Nykter · 2019 · Neurobiology of Aging
Alterations in inflammatory markers after a 12-week exercise program in individuals with schizophrenia—a randomized controlled trial
Therese Torgersen Bigseth, John Abel Engh, Eivind Andersen, Gry Bang-Kittilsen, Jens Egeland, Ragnhild Sørum Falk, Tom Langerud Holmen, Jon Mordal, Jimmi Nielsen, Thor Ueland et al. · 2023 · Frontiers in Psychiatry
Mean platelet volume, platelet count, and neutrophil/lymphocyte ratio in drug-naïve patients with schizophrenia: a cross-sectional study
Héctor Cabello-Rangel, Marisol Basurto-Morales, Elizabeth Botello-Aceves, Osiris Pazarán-Galicia · 2023 · Frontiers in Psychiatry
Reward and Immune Systems in Emotion (RISE) prospective longitudinal study: Protocol overview of an integrative reward-inflammation model of first onset of major depression in adolescence
Lauren B. Alloy, Iris Ka-Yi Chat, Mora M. Grehl, Auburn R. Stephenson, Zoe V. Adogli, Thomas M. Olino, Lauren M. Ellman, Gregory E. Miller, Robin Nusslock · 2023 · Brain Behavior & Immunity - Health
Serum Interleukin-6 in Schizophrenia: Associations with Clinical and Sociodemographic Characteristics
Tatyana Vladimirovna Zhilyaeva, Grigory V. Rukavishnikov, Elvira A. Manakova, Galina Elevna Mazo · 2023 · Consortium Psychiatricum
Association between peripheral plasma cytokine levels and suicidal ideation in first-episode, drug-naïve major depressive disorder
Xue Song Tian, Yeqing Dong, Jia-yu Yuan, Ying Hua Gao, Chuhao Zhang, Meijuan Li, Jie Li · 2024 · Psychoneuroendocrinology
Impact of Lithium on the Immune System: An Investigation of T-Cell Subpopulations and Cytokine Responses in Rats
Erdal Matur, Sibel Akyol, Selmin Toplan, Semra Özdemir, İbrahim Akyazı, Nuran Darıyerli · 2024 · Biological Trace Element Research
Targeting Toll-like Receptor 4/Nuclear Factor-κB and Nrf2/Heme Oxygenase-1 Crosstalk via Trimetazidine Alleviates Lipopolysaccharide-Induced Depressive-like Behaviors in Mice
Sarah S. Mohamed, Nora O. Abdel Rasheed, Weam W. Ibrahim, Nesma A. Shiha · 2024 · Journal of Neuroimmune Pharmacology
Psychosis of Epilepsy: An Update on Clinical Classification and Mechanism
Zhiruo Qiu, Jiahui Guo, Bofei Chen, Jiajia Fang · 2025 · Biomolecules
Comparison of thin-strut cobalt-chromium stents and stainless steel stents in a porcine model of neointimal hyperplasia.
Krzysztof P. Milewski, Aleksander Żurakowski, Jacek Pająk, Ewa Pajak-Zielinska, Łukasz Liszka, Piotr Paweł Buszman, Jarosław Bis, Marcin Dębiński, Paweł Eugeniusz Buszman · 2010 · PubMed
Changes in inflammation with treatment for bipolar II depression: Pilot trial data on differential effects of psychotherapy and medication
Jess G. Fiedorowicz, Jill M. Cyranowski, Zhuangzhuang Liu, Holly A. Swartz · 2019 · Neurology Psychiatry and Brain Research
Altered Autonomic Function in Individuals at Clinical High Risk for Psychosis
Anna Kocsis, Ruchika Gajwani, Joachim Groß, Andrew Ian Gumley, Stephen M. Lawrie, Matthias Schwannauer, Frauke Schultze‐Lutter, Tineke Grent-‘t-Jong, Peter J. Uhlhaas · 2020 · Frontiers in Psychiatry
Correlations between peripheral levels of inflammatory mediators and frontolimbic structures in bipolar disorder: an exploratory analysis
Satyajit Mohite, Haitham Hamdy Salem, Thiago Macedo e Cordeiro, Jonika D Tannous, Benson Mwangi, Sudhakar Selvaraj, Jair C. Soares, Marsal Sanches, Antônio Lúcio Teixeira · 2021 · CNS Spectrums
Exploring low grade inflammation by soluble urokinase plasminogen activator receptor levels in schizophrenia: a sex-dependent association with depressive symptoms
Therese Torgersen Bigseth, John Abel Engh, Jens Egeland, Eivind Andersen, Ole A. Andreassen, Gry Bang-Kittilsen, Ragnhild Sørum Falk, Tom Langerud Holmen, Morten Lindberg, Jon Mordal et al. · 2021 · BMC Psychiatry
Cannabis Cessation, Inflammatory Markers and Schizophrenia
Bruno Roméo, Valentine Lestra, Catherine Martelli, Amine Benyamina, Nora Hamdani · 2022 · Journal of Dual Diagnosis
Associations of Serum Cytokines, Growth Factors, and High-Sensitivity C-Reactive Protein Levels in Patients with Major Depression with and without Type 2 Diabetes Mellitus: An Explanatory Investigation
Takashi Hoshikawa, Naomichi Okamoto, Tomoya Natsuyama, Rintaro Fujii, Atsuko Ikenouchi, Yuichi Honma, Masaru Harada, Reiji Yoshimura · 2022 · Neuropsychiatric Disease and Treatment
The Pyroptosis-Related Signature Predicts Diagnosis and Indicates Immune Characteristic in Major Depressive Disorder
Zhifang Deng, Jue Liu, He Shen, Wenqi Gao · 2022 · Frontiers in Pharmacology
Changes of immune-related factors in the blood of schizophrenia and bipolar disorder patients receiving monotherapy
Fangyuan Duan, Shunan Zhao, Cuihua Xia, Zongyao Ren, Ning Yuan, Li Xie, Le Wang, Yifan Xiong, Pei Yu, Yu Chen et al. · 2022 · Translational Psychiatry
Montelukast induces beneficial behavioral outcomes and reduces inflammation in male and female rats
Ira S. Rostevanov, Batya Betesh-Abay, Ahmad Nassar, Elina Rubin, Sarit Uzzan, JACOB KAPLANSKI, Linoy Biton, Abed N. Azab · 2022 · Frontiers in Immunology
Shared and distinct functional connectivity of hippocampal subregions in schizophrenia, bipolar disorder, and major depressive disorder
Yanzhuo Song, Jingyu Yang, Miao Chang, Yange Wei, Zhiyang Yin, Yue Zhu, Yuning Zhou, Yifang Zhou, Xiaowei Jiang, Feng Wu et al. · 2022 · Frontiers in Psychiatry
Glial-Neuronal Interaction in Synapses: A Possible Mechanism of the Pathophysiology of Bipolar Disorder
Krista Minéia Wartchow, Giselli Scaini, João Quevedo · 2023 · Advances in experimental medicine and biology
The Mediating Role of Depression in Association Between Total Sleep Time and Instrumental Activities of Daily Living in China
Yunyi Wu, Sangsang Li, Dan Han, Mei Zhang, Jie V. Zhao, Hui Liao, Ying Ma, Chaoyang Yan, Jing Wang · 2023 · International Journal of Public Health
Efficacy of olokizumab against comorbid depressive disorder in patients with rheumatoid arthritis: Preliminary results of the study
Tatyana Andreyevna Lisitsyna, Абрамкин Антон Анатольевич, Dmitry Yu. Veltishchev, O. Seravina, Oksana B. Kovalevskaya, A. B. Borisova, V. G. Ignatiev, Evgeny Lvovich Nasonov · 2023 · Rheumatology Science and Practice
Predictors of successful anti-inflammatory drug trials in patients with schizophrenia: A meta-regression and critical commentary
Anjali Chandra, Brian J. Miller, David R. Goldsmith · 2023 · Brain Behavior and Immunity
Defects in AMPAR trafficking and microglia activation underlie socio-cognitive deficits associated to decreased expression of phosphodiesterase 2 a
Sébastien Delhaye, Marielle Jarjat, Asma Boulksibat, Clara Sanchez, Alessandra Tempio, Andrei Turtoï, Mauro Giorgi, Sandra Lacas‐Gervais, Gabriele Baj, Carole Rovère et al. · 2023 · Neurobiology of Disease
Levels of cytokines in the cerebrospinal fluid of patients with psychotic disorders compared to individually matched healthy controls
Rose Jeppesen, Nis Borbye‐Lorenzen, Rune Haubo Bojesen Christensen, Nina Vindegaard Sørensen, Ole Köhler‐Forsberg, Kristin Skogstrand, Michael E. Benros · 2023 · Brain Behavior and Immunity
Neuro-metabolite profiles of rodent models of psychiatric dysfunctions characterised by MR spectroscopy
Sakthivel Sekar, Joanes Grandjean, Joanne FV. Garnell, Roland Willems, Hilde Duytschaever, Sankar Seramani, Su Huang, Luc Ver Donck, Kishore Kumar Bhakoo · 2018 · Neuropharmacology
Total and Differential White Blood Cell Counts, Cocaine, and Marijuana Use in Patients With Schizophrenia
Ryan L. Goetz, Brian J. Miller · 2019 · The Journal of Nervous and Mental Disease
Exploring autoantibody signatures in brain tissue from patients with severe mental illness
David Just, Anna Månberg, Nicholas Mitsios, Craig A. Stockmeier, Grażyna Rajkowska, Mathias Uhlén, Jan Mulder, Lars Feuk, Janet L. Cunningham, Peter Nilsson et al. · 2020 · Translational Psychiatry
Cytomegalovirus infection and IQ in patients with severe mental illness and healthy individuals
Dimitrios Andreou, Kjetil Nordbø Jørgensen, Laura Anne Wortinger, Kristine Engen, Anja Vaskinn, Torill Ueland, Robert H. Yolken, Ole A. Andreassen, Ingrid Agartz · 2021 · Psychiatry Research
Higher Dietary Inflammation in Patients with Schizophrenia: A Case-Control Study in Korea
Hee Shon Yun, Soo Jin Yang, Sung‐Wan Kim · 2021 · Nutrients
Attenuated transcriptional response to pro-inflammatory cytokines in schizophrenia hiPSC-derived neural progenitor cells
Anjali Bhat, Haritz Irizar, Amalie C. M. Couch, Pooja Raval, Rodrigo R. R. Duarte, Lucia Dutan Polit, Bjørn Hanger, Timothy R. Powell, P. J. Michael Deans, Carole Shum et al. · 2022 · Brain Behavior and Immunity
Involvement of inflammatory responses in the brain to the onset of major depressive disorder due to stress exposure
Shingo Miyata, Yugo Ishino, Shoko Shimizu, Masaya Tohyama · 2022 · Frontiers in Aging Neuroscience
Active Fraction of Polyrhachis Vicina Roger (AFPR) Ameliorate Depression Induced Inflammation Response by FTO/miR-221-3p/SOCS1 Axis
Junhui He, Jiaxiu Xie, Guili Zhou, Chunlian Jia, Dongbo Han, Dongmei Li, Jie Wei, Yi Li, Renshan Huang, Chunlian Li et al. · 2023 · Journal of Inflammation Research
A composite immune and vascular stress marker in patients newly diagnosed with bipolar disorder and their unaffected first-degree relatives
Klara Coello, Helle Holstad Pedersen, Klaus Munkholm, Hanne Lie Kjærstad, Sharleny Stanislaus, Sisse Rye Ostrowski, Maria Faurholt‐Jepsen, Kamilla Woznica Miskowiak, Ruth Frikke‐Schmidt, Maj Vinberg et al. · 2024 · Brain Behavior and Immunity
Dysregulation of interleukin-8 is involved in the onset and relapse of schizophrenia: An independent validation and meta-analysis
Junwei Yan, Qingrong Xia, Xuejun Sun, Pei Yang, Hua Gao, Zhongde Pan, Jianliang Gao, Loufeng Zhang, Meiti Wang, Keming Wang et al. · 2024 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
The combined effects of depression or anxiety with high-sensitivity C-reactive protein in predicting the prognosis of coronary heart disease patients
Bingqing Bai, Han Yin, Haochen Wang, Fengyao Liu, Yanting Liang, Anbang Liu, Lan Guo, Huan Ma, Qingshan Geng · 2024 · BMC Psychiatry
Key role of PPAR-γ-mediated suppression of the NFκB signaling pathway in rutin's antidepressant effect
Shu-Yuan Yin, Xin-Xin Shao, Shi-Yu Shen, Jiarui Zhang, Zu-Qi Shen, Ling‐Feng Liang, Cong Chen, Na Yue, Xianjun Fu, Jin Ming Yu · 2024 · Phytomedicine
Rethinking the studies of diagnostic biomarkers for mental disorders
Jin Liu, Haoting Wang, Lingjiang Li · 2025 · Meta-Radiology
Beyond weight loss: exploring the neurological ramifications of altered gut microbiota post-bariatric surgery
Rashed T. Almheiri, Baraa Mohammed Hajjar, Saif M I Alkhaaldi, Nadia Rabeh, Sara Aljoudi, Khaled S. Abd‐Elrahman, Hamdan Hamdan · 2025 · Journal of Translational Medicine
Evaluation of Pan-immune Inflammation Value and Systemic Immune Inflammation Index in Different Mood Episodes of Bipolar Disorder
Medine Gıynaş Ayhan, Hazel Demiröz Öztürk, İkbal İnanlı · 2025 · Clinical Psychopharmacology and Neuroscience
The Immune/Inflammatory Underpinnings of Neurodevelopmental Disorders and Pediatric Acute-Onset Neuropsychiatric Syndrome: A Scoping Review
Antonella Gagliano, Francesca Cucinotta, Ivana Giunta, Irene Di Modica, Carmela De Domenico, Carola Costanza, Eva Germanò, Jennifer Frankovich · 2025 · International Journal of Molecular Sciences
¿Pueden ser la interleucina-2 y la interleucina-1β biomarcadores específicos de la sintomatología negativa en la esquizofrenia?
Leticia González-Blanco, María Paz García‐Portilla, Leticia García-Álvarez, Lorena de la Fuente-Tomás, Celso Iglesias García, Pilar Alejandra Sáiz, Susana Rodríguez‐González, Ana M. Coto‐Montes, Julio Bobes · 2018 · Revista de Psiquiatría y Salud Mental
Adjunctive Garcinia mangostana Linn. (Mangosteen) Pericarp for Schizophrenia: A 24-Week Double-blind, Randomized, Placebo Controlled Efficacy Trial: Péricarpe d’appoint Garcinia mangostana Linn (mangoustan) pour la schizophrénie : un essai d’efficacité de 24 semaines, à double insu, randomisé et contrôlé par placebo
Alyna Turner, Andrea Baker, Olivia May Dean, Adam J. Walker, Seetal Dodd, Sue Cotton, James G. Scott, Bianca E. Kavanagh, Melanie M. Ashton, Ellie Brown et al. · 2020 · The Canadian Journal of Psychiatry
Does Participation in Food Benefit Programs Reduce the Risk for Depressive Symptoms?
Harry Adynski, Todd A. Schwartz, Hudson Pires de Oliveira Santos Junior · 2021 · Journal of the American Psychiatric Nurses Association
Monocyte Transcriptional Profiling Highlights a Shift in Immune Signatures Over the Course of Illness in Schizophrenia
Jennifer K. Melbourne, Cherise Rosen, Kayla A. Chase, Benjamin Feiner, Rajiv P. Sharma · 2021 · Frontiers in Psychiatry
Cerebrospinal fluid test results and associations with subsequent mental disorders, neurological diseases, and CNS infections: A population-based cohort study
Sonja Orlovska‐Waast, Liselotte Vogdrup Petersen, Christiane Gasse, Merete Nordentoft, Preben Bo Mortensen, Daniel Kondziella, Michael E. Benros · 2021 · Brain Behavior and Immunity
Investigation of the correlation between mood disorder symptoms and disease activity and functional status in rheumatoid arthritis patients
Melih Pamukçu, Tuğba İzci Duran, Hasan Ulusoy, Kürşat Altınbaş · 2021 · TURKISH JOURNAL OF MEDICAL SCIENCES
Pre-treatment plasma cytokine levels as potential predictors of short-term remission of depression
Kiyokazu Atake, Hikaru Hori, Yuki Kageyama, Yosuke Koshikawa, Ryohei Igata, Hirotaka Tominaga, Asuka Katsuki, Hiroki Bando, Shiho Sakai, Keiichiro Nishida et al. · 2022 · The World Journal of Biological Psychiatry
Interleukin-8 and tumor necrosis factor-alpha in youth with mood disorders—A longitudinal study
Maria Skibińska, Aleksandra Rajewska‐Rager, Monika Dmitrzak‐Węglarz, Paweł Kapelski, Natalia Lepczyńska, Mariusz Kaczmarek, Joanna Pawlak · 2022 · Frontiers in Psychiatry
The Inflammatory Signals Associated with Psychosis: Impact of Comorbid Drug Abuse
Jesús Herrera-Imbroda, María Flores-López, Paloma Ruiz-Sastre, Carlos Gómez Sánchez-Lafuente, Antonio Bordallo-Aragón, Fernando Rodrı́guez de Fonseca, Fermín Mayoral · 2023 · Biomedicines
Microbiome-Induced Autoimmunity and Novel Therapeutic Intervention
Alper Evrensel · 2023 · Advances in experimental medicine and biology
Peripheral inflammation is associated with impairments of inhibitory behavioral control and visual sensorimotor function in psychotic disorders
Lusi Zhang, Paulo L. Lizano, Yanxun Xu, Leah H. Rubin, Adam M. Lee, Rebekka Lencer, James L. Reilly, Richard S.E. Keefe, Sarah Keedy, Godfrey D. Pearlson et al. · 2023 · Schizophrenia Research
Potential role between inflammatory cytokines and Tie-2 receptor levels and clinical symptoms in patients with first-episode schizophrenia
Fanfan Yan, Xiaojing Meng, Xialong Cheng, Wenzhi Pei, Yuanyuan Chen, Long Chen, Mingming Zheng, Li Shi, Cuizhen Zhu, Xulai Zhang · 2023 · BMC Psychiatry
Mediterranean Diet Adherence and Depressive Symptoms among a Nationally Representative Sample of Pregnant Women in the United States
Vanessa M. Oddo, Crussie Moise, Lauren Welke, Beatriz Peñalver Bernabé, Pauline M. Maki, Mary Dawn Koenig, Lacey Pezley, Yinglin Xia, Lisa Marie Tussing-Humphreys · 2023 · Journal of Nutrition
Effects of low-dose aspirin in bipolar disorder: study protocol for a randomised controlled trial (the A-Bipolar RCT)
Caroline Fussing Bruun, Jeff Zarp, Julie Lyng Forman, Klara Coello, Kamilla Woznica Miskowiak, Maj Vinberg, Maria Faurholt‐Jepsen, Lars Vedel Kessing · 2024 · BMJ Open
Altered gene expression in lymphoblastoid cell lines after subculture
Michihiro Toritsuka, Manabu Makinodan, Takahira Yamauchi, Yasunori Yamashita, Daisuke Ikawa, Takashi Komori, Sohei Kimoto, Kaori Hamano-Iwasa, Hideo Matsuzaki, Taishiro Kishimoto · 2018 · In Vitro Cellular & Developmental Biology - Animal
Elevation of tumor necrosis factor alpha levels is associated with restless legs symptoms in clinically depressed patients
Piritta Auvinen, Pekka T Mäntyselkä, Hannu Koponen, Hannu Kautiainen, Katariina Korniloff, Tiina Ahonen, Mauno J. Vanhala · 2018 · Journal of Psychosomatic Research
NRF2 and HMOX1 Gene Expression against the Background of Systemic Oxidative Stress in Patients with Acute Psychosis
Г. В. Шмарина, Maria Orlova, Elizaveta Sergeevna Ershova, Elizaveta M. Jestkova, А. В. Мартынов, Natalia Nikolaevna Veiko, Marina S. Konkova, Olga А. Dolgikh, Anton D. Filev, Svetlana V. Kostyuk · 2020 · Russian Journal of Genetics
C-Reactive Protein as a Possible Predictor of Trail-Making Performance in Individuals with Psychiatric Disorders
Nina Dalkner, Eva Z. Reininghaus, Karin Schwalsberger, Alexandra Rieger, Carlo Hamm, René Pilz, Melanie Lenger, Robert Queissner, Valerie S. Falzberger, Martina Platzer et al. · 2020 · Nutrients
Influence of dietary habits on depression among patients with rheumatoid arthritis: A cross-sectional study using KURAMA cohort database
Hiroto Minamino, Masao Katsushima, Motomu Hashimoto, Yoshihito Fujita, Mie Torii, Kaori Ikeda, Nozomi Isomura, Yasuo Oguri, Wataru Yamamoto, Ryu Watanabe et al. · 2021 · PLoS ONE
Safety and Efficacy of Combined Low-Dose Lithium and Low-Dose Aspirin: A Pharmacological and Behavioral Proof-of-Concept Study in Rats
Rachel Shvartsur, Galila Agam, Alla Shnaider, Sarit Uzzan, Ahmad Nassar, Adi Jabarin, Naim Abu‐Freha, Karen S. Meir, Abed N. Azab · 2021 · Pharmaceutics
Exogenous Carbon Monoxide Produces Rapid Antidepressant- and Anxiolytic-Like Effects
Yixiao Luo, Rafi Ullah, Jinfeng Wang, Yuru Du, Shihao Huang, Meng Li, Yuan Gao, Miao Gong, Ewa Galaj, Xi Yin et al. · 2021 · Frontiers in Pharmacology
Neuroimmunological investigations of cerebrospinal fluid in patients with recent onset depression – a study protocol
Nina Vindegaard Sørensen, Sonja Orlovska‐Waast, Rose Jeppesen, Rune Haubo Bojesen Christensen, Michael E. Benros · 2022 · BMC Psychiatry
Impact of history of mental disorders on short-term mortality among hospitalized patients with sepsis: A population-based cohort study
Lavi Oud, John Garza · 2022 · PLoS ONE
Correlation Between Serum High-Sensitivity C-Reactive Protein, Tumor Necrosis Factor-Alpha, Serum Interleukin-6 and White Matter Integrity Before and After the Treatment of Drug-Naïve Patients With Major Depressive Disorder
Liping Chen, Xiangling Zeng, Sijia Zhou, Zhiwen Gu, Jiyang Pan · 2022 · Frontiers in Neuroscience
Visceral adipose tissue in patients with severe mental illness
Kai G. Kahl, Michael Deuschle, Brendon Stubbs, Ulrich Schweiger · 2018 · Hormone Molecular Biology and Clinical Investigation
The Relationship between Cytokines and Verbal Memory in Individuals with Schizophrenia and Their Unaffected Siblings
Diego Barreto Rebouças, Francisco Diego Rabelo‐da‐Ponte, Raffael Massuda, Letícia Sanguinetti Czepielewski, Clarissa Severino Gama · 2018 · NeuroImmunoModulation
The JAK-STAT1 transcriptional signature in peripheral immune cells reveals alterations related to illness duration and acuity in psychosis
Jennifer K. Melbourne, Cherise Rosen, Benjamin Feiner, Yanzhen Pang, Rajiv P. Sharma · 2018 · Brain Behavior and Immunity
Study protocol of comprehensive risk evaluation for anorexia nervosa in twins (CREAT): a study of discordant monozygotic twins with anorexia nervosa
Maria Seidel, Stefan Ehrlich, Lauren E. Breithaupt, Elisabeth Welch, Camilla A. Wiklund, Christopher Hübel, Laura M. Thornton, Androula Savva, Bengt T. Fundín, Jessica Pege et al. · 2020 · BMC Psychiatry
Antipsychotics and Their Impact on Cerebral White Matter: Part of the Problem or Part of the Solution?
Marek R. Kubicki, Amanda E. Lyall · 2018 · American Journal of Psychiatry
Polygenic risk for immuno-metabolic markers and specific depressive symptoms: A multi-sample network analysis study
Nils Kappelmann, Darina Czamara, Nicolas Rost, Sylvain Moser, Vanessa Schmoll, Lucia Trastulla, Jan Štochl, Susanne Lucae, CHARGE inflammation working group, Elisabeth B. Binder et al. · 2021 · medRxiv
Serum NOX1 and Raftlin as New Potential Biomarkers of Interest in Schizophrenia: A Preliminary Study
Onur Hurşıtoğlu, Ergül Belge Kurutaş, Rebecca Strawbridge, Ömer Faruk Uygur, Emrah Yildiz, Thomas James Reilly · 2022 · Neuropsychiatric Disease and Treatment
A Novel Anti-Inflammatory Formulation Comprising Celecoxib and Cannabidiol Exerts Antidepressant and Anxiolytic Effects
Eyal Dinur, Hagar Goldenberg, Elad Robinson, Lior Naggan, Ewa Kozela, Raz Yirmiya · 2022 · Cannabis and Cannabinoid Research
Immunoinflammatory features and cognitive function in treatment-resistant schizophrenia: unraveling distinct patterns in clozapine-resistant patients
Yanzhe Li, Minghuan Zhu, Yeqing Dong, Nannan Liu, Xinxu Wang, Bing Yang, Zezhi Li, Shen Li · 2024 · European Archives of Psychiatry and Clinical Neuroscience
Pathophysiological Mechanisms of Psychosis-Induced Atrial Fibrillation: The Links between Mental Disorder and Arrhythmia
Pao‐Huan Chen, Yu‐Hsun Kao, Yi‐Jen Chen · 2024 · Reviews in Cardiovascular Medicine
Psychoneuroimmunology of Mood Disorders
Antônio Lúcio Teixeira, Juliete Nathali Scholl, Moisés Evandro Bauer · 2024 · Methods in molecular biology
Fasting the brain for mental health
Roberto Carlos Pérez‐Kast, Alberto Camacho‐Morales · 2024 · Journal of Psychiatric Research
Deep immunophenotyping of circulating immune cells in major depressive disorder patients reveals immune correlates of clinical course and treatment response
Fabiola Stolfi, Claudio Brasso, Davide Raineri, Virginia Landra, Camilla Barbero Mazzucca, Ali Ghazanfar, Lorenza Scotti, Riccardo Sinella, Vincenzo Villari, Giuseppe Cappellano et al. · 2024 · Brain Behavior & Immunity - Health
Autistic Traits in Schizophrenia: Immune Mechanisms and Inflammatory Biomarkers
Maria Suprunowicz, Mateusz Zwierz, Beata Konarzewska, Napoleon Waszkiewicz · 2025 · International Journal of Molecular Sciences
The role of the microbiota-gut-brain axis in schizophrenia: an immunological perspective
Bo-Wei Su, Yao Li, Le-Ying Yang, Haixia Yang, Wenhao Wang, Huiwen Ren, Ya-Nan Bao, Jia-Yi Lao, Zhi‐Lin Luan · 2025 · Frontiers in Immunology
Interleukin 6 as a Treatment Target for Depression
Éimear M. Foley, Nicholas L Turner, Ruta Margelyte, Hannah J Jones, Muzaffer Kaşer, Glyn Lewis, Peter Brian Jones, Golam Mohammed Khandaker · 2026 · JAMA Psychiatry
Impact of SARS-CoV-2 on Host Factors Involved in Mental Disorders
Raina E. Rhoades, Sarah Solomon, Christina Johnson, Shaolei Teng · 2022 · Frontiers in Microbiology
The Immune System and Depression: From Epidemiological to Clinical Evidence
Nina Vindegaard Sørensen, Michael E. Benros · 2022 · Current topics in behavioral neurosciences
Serum cytokine variations among inpatients with major depression, bipolar disorder, and schizophrenia versus healthy controls: a prospective ‘true-to-life’ study
Antônio Augusto Schmitt Júnior, Lucas Primo de Carvalho Alves, Barbara Larissa Padilha, Neusa Sica da Rocha · 2023 · Therapeutic Advances in Psychopharmacology
Contributions of circadian clock genes to cell survival in fibroblast models of lithium-responsive bipolar disorder
Himanshu K. Mishra, Heather Wei, Kayla E. Rohr, Insu Ko, Caroline M. Nievergelt, Adam X. Maihofer, Paul D. Shilling, Martin Alda, Wade H. Berrettini, Kristen Brennand et al. · 2023 · European Neuropsychopharmacology